Applied Biosciences Corp 55336VAG5 Bond
APPBDelisted Stock | USD 0.0009 0.00 0.00% |
Applied Biosciences Corp holds a debt-to-equity ratio of 1.009. With a high degree of financial leverage come high-interest payments, which usually reduce Applied Biosciences' Earnings Per Share (EPS).
Applied |
Given the importance of Applied Biosciences' capital structure, the first step in the capital decision process is for the management of Applied Biosciences to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Applied Biosciences Corp to issue bonds at a reasonable cost.
Popular Name | Applied Biosciences MPLX LP 4875 |
Specialization | Restaurants |
Equity ISIN Code | US03815L1026 |
Bond Issue ISIN Code | US55336VAG59 |
S&P Rating | Others |
Maturity Date | 1st of December 2024 |
Issuance Date | 1st of June 2016 |
Coupon | 4.875 % |
Applied Biosciences Corp Outstanding Bond Obligations
Dana 575 percent | US235822AB96 | Details | |
Volcan Compania Minera | USP98047AC08 | Details | |
Boeing Co 2196 | US097023DG73 | Details | |
HSBC Holdings PLC | US404280DR76 | Details | |
MPLX LP 4875 | US55336VAG59 | Details | |
MPLX LP 4125 | US55336VAK61 | Details | |
MPLX LP 52 | US55336VAL45 | Details | |
International Game Technology | US460599AD57 | Details | |
BNP Paribas FRN | USF1R15XK367 | Details | |
MGM Resorts International | US552953CD18 | Details | |
AerCap Global Aviation | US00773HAA59 | Details |
Understaning Applied Biosciences Use of Financial Leverage
Applied Biosciences' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Applied Biosciences' total debt position, including all outstanding debt obligations, and compares it with Applied Biosciences' equity. Financial leverage can amplify the potential profits to Applied Biosciences' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Applied Biosciences is unable to cover its debt costs.
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeuticsbiopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. The company was incorporated in 2014 and is based in Beverly Hills, California. APPLIED BIOSCIENCES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 25 people. Please read more on our technical analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Biosciences Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Biosciences' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.